News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

GC INK™ NEUTRALIZES 100 PERCENT OF CORONAVIRUS AND INFLUENZA VIRUSES IN UNDER ONE MINUTE

Graphene Composites

GC Ink™ neutralizes 100 PERCENT of Coronavirus OC43 and Influenza A virus H1N1 in under one minute Deployed in PPE, air filters and cleaning products to neutralize viruses and bacteria Supports the safe reopening of schools and public buildings Independent tests conducted by Brown University, published recently GC is working with several partners to apply GC Ink™ across a broad range of products As the world's eyes remain focused on the rollout of the COVID-19 vaccines, Graphene Composites, a leading, global nano-materials engineering company, has unveiled a new technology - GC Ink™ - that could make our most vulnerable public spaces safer from the transmission of viruses and bacteria, including Coronavirus, by neutralizing them. GC Ink™ has been independently tested by Brown University to show 100 percent effectiveness at neutralizing coronavirus and influenza viruses in under one minute, and the findings have been published on bioRxiv. This fast-acting, extremely effective, and safe formulation of graphene and silver nanoparticles can be applied to masks and other PPE, and in particular, applied to filters in ventilation systems. When used in filters and masks, GC Ink™ is highly effective at trapping and neutralizing airborne coronaviruses and other viruses/bacteria for several weeks. When used in wipes, GC Ink also leaves a thin, highly effective, safe layer of protection against viruses and bacteria that lasts for 24 hours. GC’s technology is highly effective because it has a dual-action mechanism: the negatively-charged surface of graphene oxide traps the positively-charged parts of water droplets and the protein spikes on coronavirus; the silver nanoparticles release ions that oxidize the lipid membrane protecting coronavirus RNA, thereby neutralizing it. “Making the air that we breathe and the surfaces that we touch much safer could be a key enabler in the safe reopening of schools and other public spaces." said Sandy Chen, GC CEO & Co-Founder. "GC Ink™ is a powerful weapon against not only this pandemic, but against a broad range of viruses and bacteria. We are now moving into full commercialization of our GC Ink™ with several manufacturing partners in a wide variety of applications, from masks to filters to consumer goods.” Brown’s top respiratory virologist, Amanda M. Jamieson, Ph.D., Assistant Professor of Molecular Microbiology and Immunology, who led the tests, said, “Our results show that this technology is very effective at preventing infection by two important respiratory viruses which clearly has important implications for this pandemic and the next one.” As demand for GC Ink™ rises, Graphene Composites is well positioned to scale production to meet demand across the United States and worldwide, with the State of Rhode Island-funded Nanomaterials Center of Excellence at 401 Tech Bridge serving as a key production facility. Brown is now in the process of testing the virus in a BSL3 facility in partnership with the Rhode Island Dept of Health (RIDOH). Because the tested Coronavirus OC43 and SARS-CoV-2 (which causes Covid-19) have similar structures, it is expected that GC Ink™ will prove to be similarly effective against SARS-CoV-2 coronavirus. GC Ink™ formulations are protected by patents pending. About Graphene Composites: Graphene Composites is a world leader in nanomaterials engineering. We are driven by our ethos – GC for Good – working with our partners to apply our expertise in graphene and other nanomaterials engineering to make truly life-enhancing products. About Brown University: Brown’s Jamieson Lab conducted the tests in their Bio Safety Level 2 (BSL2) labs in Providence, Rhode Island, using a standard plaque assay approach, similar to the ISO international standards for anti-viral testing. Further tests are underway. About Graphene Composites: Graphene Composites is a world leader in nanomaterials engineering. We are driven by our ethos - GC for Good - working with our partners to apply our expertise in graphene and other nanomaterials engineering to make truly life-enhancing products. About Brown University: Brown's Jamieson Lab conducted the tests in their Bio Safety Level 2 (BSL2) labs in Providence, Rhode Island, using a standard plaque assay approach, similar to the ISO international standards for anti-viral testing. Further tests are underway. Contact Details Graphene Composites John R. “J.R.” Pagliarini +1 401-261-5811 jr@graphenecomposites.com Company Website https://graphenecomposites.com/

March 02, 2021 09:45 AM Eastern Standard Time

Image
Article thumbnail News Release

Cloud Conventions 2021 – The Premier Telecom/Cloud Channel Virtual Event Returns Live May 12-14

Convey Services

Cloud Conventions 2021 will open its 2nd annual virtual conference and tradeshow on May 12-14 offering a unique experience for channel professionals in the telecom/cloud, hosted voice, connectivity, IT and managed services and mobility industries. Co-sponsored by media partner, TR Publications and managed by the MCI Group, this premier industry event redefines the attendee and exhibitor experience for a virtual event with industry and business content, discussions opportunities, networking and strategy sessions, along with more ways to connect individually with peers and exhibitors. “Channel Strategies to Navigate the ‘New Normal’ is the focus of Cloud Conventions 2021,” said Carolyn Bradfield, CEO of Convey Services, founding partner of the event. “We teamed with the MCI Group as our event management partner and TR Publications and their related media to build on the success of our Cloud Conventions 2020 event expanding offerings and audience. Our experience delivering dozens of virtual tradeshows, conferences, summits, and kick-off meetings for our clients has taught us how to design an virtual expo avoiding the pitfalls of events that fail to create an engaging experience for attendees and deliver sales leads to exhibitors and sponsors." "Cloud Conventions 2021 has the potential to bring together one of the largest audiences of channel partners, MSPs, VARs, IT service providers and carriers for an unparalleled virtual event,” said Doug Green, publisher of TR Publications. “Strategies to deliver cloud solutions, connectivity, mobility and managed services are evolving, along with the business models of channel organizations that provide them to business customers. Cloud Conventions 2021 brings together resources, thought leaders, technology and business solutions to ensure that the channel has the tools to thrive in this rapidly changing landscape.” “Managing Cloud Conventions 2021 opens up a vast new market opportunity for the MCI Group,” said James Kelley Director of Business Development, Virtual Events at MCI USA. “Our team has partnered with Convey and their Cloud Conventions virtual event platform to deliver large virtual tradeshows and conferences for the past year. We offer added value to a show like this through marketing and our event management experience and support for exhibitors and sponsors. The MCI Group is committed to growing the Cloud Conventions 2021 event and returning in the spring of 2022 with an even larger live and hybrid industry expo.” In May of last year, the Cloud Conventions 2020 event attracted thousands of attendees over 4 days, with industry sponsors, social engagement and networking, and 78 educational sessions to help channel partners develop pathways to get business back on track and help their customers pivot to a digital work environment in the face of the pandemic. The 2021 virtual event will help channel partners navigate the ‘new normal’ by offering connections to colleagues and providers, powerful educational sessions, along with strategies to stay personally and professionally resilient, agile, and informed. Attendance at Cloud Conventions 2021 is free to qualified industry professionals. Past attendees will receive an invitation to pre-register. New attendees and potential exhibitors can sign up at www.cloudconventions2021.com. The Cloud Conventions 2021 conference and expo is hosted and managed on the industry leading Cloud Conventions virtual event platform, powered by Convey Services. About Telecom Reseller TR Publications reports on UC, UCaaS, CPaaS, mobility, telehealth, SD-WAN, direct routing, collaboration are among the many topics covered. Written for both buyer and seller, IT director and channel leader, TR’s qualified readers include enterprise end users, channel partners, MSPs, CLECs. Content includes news, blogs, podcasts, Educasts, and webinars. TR reaches 25,000 readers daily by eBulletin, 80,000 readers every weekend with their Sunday Report, and 1,900 people daily online. www.telecomreseller.com. About MCI Group MCI is a global engagement and marketing agency. We design human-centric solutions that unleash the power of people to deliver innovation and growth for our clients. Our offering includes live & virtual events, strategic & digital communications, consulting & community solutions. We help brands, companies, associations and not-for-profits solve their challenges, bringing their people together to shape their tomorrow. MCI is an independently owned company headquartered in Geneva, Switzerland, with a global presence in 60 offices across 31 countries. www.mci-group.com About Cloud Conventions Cloud Conventions is a Virtual Trade Show and Conference Platform from Convey Services that brings new capabilities to a marketplace looking for solutions to replace the thousands of live trade shows, annual conferences and association meetings cancelled in the wake of COVID-19. Originally launched as ConveyLive, Cloud Conventions automates exhibitors and virtual booths, attendee registration, speaker sessions and reminders, invitations and email communication, while at the same time producing detailed analytics on attendee, session and exhibitor activity. Trade Associations and event managers can explore all of the Cloud Conventions solutions by visiting https://cloudconventions.com or contacting info@cloudconventions.com or call 888-975-1382. Cloud Conventions™, Community™, Cloud Kickoffs™, Conduct™, One-Touch Email Share™, Hub & Spoke™, 360° Virtual Exhibit Hall & Lobby Experience™ and ListLock™ are trademarks of Convey Services LLC Contact Details Convey Services Bruce Ahern +1 770-580-0810 bahern@conveyservices.com Company Website https://cloudconventions.com

February 26, 2021 02:30 PM Eastern Standard Time

Article thumbnail News Release

Survey Reveals Permanent Changes in Behavior and Expectations Beyond COVID-19 Vaccine Rollout

Metova Inc.

Metova, a leading provider of custom software solutions for mobile, web, connected home and car, and Internet of Things (IoT) for the private and public sector today announced the results of their latest blind survey of over 1000 people in the United States regarding behavior, trends and expectations beyond the COVID-19 vaccine rollout. Notably, “curbside pickup” led the way as the “most helpful thing” during COVID-19, outpacing video calling, online video streaming, telemedicine and mobile food and grocery services. In addition, of those who plan on getting the COVID-19 vaccine, 64% will avoid staying in a hotel, casino or resort for the remainder of 2021 if given the option. A notable, positive finding of the survey: “Quality Family Time” leads by nearly 2 to 1 in “positive life events that came out of the pandemic” – outpacing new hobbies, skills, personal fitness and home improvements. For a freely reusable infographic summarizing Metova’s Winter 2021 Post-Vaccine COVID-19 Survey, visit: https://metova.com/infographic-expectations-beyond-covid-19/ “At Metova in our work with telehealth, mobile tech, smart home and connected technologies for the hotel and hospitality industry, it’s essential we understand the quickly evolving sentiment and preferences of our clients' customers,” said Jonathan Sasse, chief strategy officer at Metova. "COVID-19 has accelerated and in many cases truly disrupted consumer preferences and behavior, and it’s essential for industries to understand these changes in order to best serve their customers.” Metova’s Winter 2021 Post-Vaccine COVID-19 Survey: “Curbside Pickup” lead the way as the “most helpful thing” during COVID-19, outpacing video calling, online video streaming, telemedicine and mobile food and grocery services “Quality Family Time” leads the way by nearly 2 to 1 in positive life events that came out of the pandemic, outpacing new hobbies, skills, personal fitness and home improvements 86% of people working from home due to COVID-19 want to continue working from home after getting the vaccine 64% after receiving the COVID-19 vaccine, if given the option, will avoid staying in a hotel, casino or resort for the remainder of 2021 1 in 4 say they won’t get the COVID-19 vaccine because they don’t think it is safe Additional Metova technology and culture sentiment surveys include: Telehealth, Contact Tracing and COVID-19, Working From Home Due to COVID-19, Internet of Things, Mobile First, the Connected Car and Smartphones and Healthcare. For a a summary of Metova 2020 survey findings, please visit: https://metova.com/metova-industry-intelligence-survey-findings-of-2020/ ABOUT METOVA Founded in 2006, with a belief that mobile would be even more transformative than the internet, Metova set out to build innovative mobile applications while also creating a great place for people to work. Today, Metova continues to build on its success by retaining world-class talent and helping companies transform their business through technology. After identifying customer needs, informed through industry-trusted surveys and analysis, Metova defines and builds the experiences customers expect, aligned with business goals to streamline workflows and increase revenues – while delighting customers and disrupting industries. Contact Details Metova Anders Steele +1 323-909-2341 anders.steele@metova.com Company Website https://metova.com

February 26, 2021 09:29 AM Eastern Standard Time

Article thumbnail Digital Asset Direct

Infographic: Permanent Changes in Behavior and Expectations Beyond COVID-19 Vaccine Rollout

Metova Inc.

Contact Details Metova Anders Steele +1 323-909-2341 anders.steele@metova.com Company Website https://metova.com/infographic-expectations-beyond-covid-19/

February 26, 2021 09:19 AM Eastern Standard Time

Image
Article thumbnail News Release

Shatterproof Releases a Comprehensive Addiction Language Guide to Reduce Use of Stigmatizing Language

Shatterproof

Today, Shatterproof, a national nonprofit organization dedicated to reversing the addiction crisis in the United States, released the Shatterproof Addiction Language Guide, which is a comprehensive tool aimed to highlight stigmatizing language, replacing it with person-first terminology. Stigmatizing language assigns negative labels, stereotypes, and judgment to certain groups of people. Such language can contribute to negative outcomes such as social isolation, reduced self-esteem, and less likelihood to seek medical help. Eliminating stigmatizing language is a core component of Shatterproof’s National Movement to End Addiction Stigma. “Words matter and they hugely impact how those with substance use disorders are viewed and therefore treated. This can affect many aspects of an individual’s life from how they feel about themselves, how they are treated by healthcare professionals when seeking treatment, and from their family and friends whose negative language can generate discrimination and internalized stigma. It is important that we create a society where those who use drugs or those who are in recovery are viewed as a person rather than their medical condition or through their actions,” said Matthew Stefanko, Director, National Stigma Initiative, Shatterproof. The Addiction Language Guide was compiled after a thorough, in-depth review of the academic literature as well as existing language guides for mental and behavioral health. Common words such as “addict” and less common stigmatizing words such as “relapse” were compiled by Shatterproof staff. The guide gives recommended language and rationale, and it has been thoroughly reviewed by the National Academy of Medicine. The National Academy of Medicine’s Action Collaborative on Countering the U.S. Opioid Epidemic facilitated an independent, blinded, and academically rigorous external peer review of the Addiction Language Guide on a pro-bono basis. The guide helps the public look deeply at the words they are using and examine the terminology they use when describing people who have a substance use disorder. “The words become grenades—strategically spoken at times in order to do the most damage. And when those words came from family and friends, they cut even deeper. These labels erased my humanity,” said Marissa Angerer, Shatterproof Ambassador and person in recovery. To download the Shatterproof Addiction Language Guide please visit, http://shatterproof.org/language. You may learn more about Shatterproof’s National Movement to End Stigma here, https://www.shatterproof.org/our-work/ending-addiction-stigma/plan-to-end-addiction-stigma. About Shatterproof: Shatterproof is a national nonprofit organization dedicated to reversing the addiction crisis in the United States. Shatterproof harnesses the models of business, the rigor of science and the power of a national movement to create change and save lives through three pillars of work: revolutionizing the addiction treatment system, breaking down addiction-related stigmas and supporting and empowering our communities. To learn more visit www.Shatterproof.org. Contact Details Shatterproof Holly Jespersen +1 646-334-1024 hjespersen@shatterproof.org Company Website https://www.shatterproof.org/

February 26, 2021 08:07 AM Eastern Standard Time

Article thumbnail News Release

Bills Introduced in Senate, House Call for New Markets Tax Credit to Receive Permanent Extension at $5 Billion

New Markets Tax Credit Coalition

Today, Reps. Terri Sewell (D-AL), Tom Reed (R-NY), Sens. Ben Cardin (D-MD) and Roy Blunt (R-MO) introduced the New Markets Tax Credit (NMTC) Extension Act of 2021. The legislation permanently extends NMTC at $5 billion in annual credit authority, adjusts that amount for inflation in future years and provides an exception from the Alternative Minimum Tax (AMT) for New Markets investments. This legislation builds on recent important Congressional action in support of NMTC. In 2019, Congress increased the amount of credits available to $5 billion, a 44% increase and in the recently enacted Consolidated Appropriations Act, the NMTC was extended through 2025. The credit recently received a five-year extension as part of COVID-relief, but establishing the NMTC as a permanent part of the tax code will provide certainty in delivering resources to low-income and marginalized communities, creating jobs, increasing economic opportunity and improving lives at a time when the economic frailty of our underserved communities has never been more apparent. The projected annual impact of $25 billion in New Markets Tax Credits includes an estimated 690 new manufacturing expansions and industrial projects; 275 mixed-use projects combining housing, commercial, and social services; 255 new or improved health clinics, hospitals, and medical offices; and 775 investments in daycare centers, Boys and Girls Clubs, and other community facilities. It will also generate an estimated 590,000 jobs. Established in 2000 in the Community Renewal Tax Relief Act (P. L. 106-554), the New Markets Tax Credit is a bipartisan effort to stimulate investment and economic growth in low-income urban neighborhoods and rural communities. Since then, the New Markets Tax Credit has financed more than 6,500 projects and created over one million jobs in all 50 states, the District of Columbia and Puerto Rico. “Following devastating impacts from COVID-19, the New Markets Tax Credit is absolutely vital for many of America’s urban neighborhoods and rural communities and will provide billions of dollars for high-impact, community revitalization projects,” said Bob Rapoza, spokesperson for the NMTC Coalition. “Over the years, the credit has been instrumental in financing plant and equipment for small manufacturing businesses and patient flexible capital to other small businesses, hospitals, healthcare centers, homeless shelters and other transformative projects that improve communities, create jobs and economic opportunity. We appreciate the leadership of several Members of Congress in championing this effort for communities across the U.S., including Reps. Terri Sewell (D-AL) and Tom Reed (R-NY) and Sens. Ben Cardin (D-MD) and Roy Blunt (R-MO).” For examples of how the NMTC is making an impact in each state, see the NMTC Coalition's newly released report, NMTC at Work in Communities Across America, featuring updated state statistics sheets on NMTC efficacy and more than 80 Tax Credit success stories. About New Markets Tax Credit Program The New Markets Tax Credit (NMTC) was enacted in 2000 in an effort to stimulate private investment and economic growth in low-income urban neighborhoods and rural communities that lack access to the patient capital needed to support and grow businesses, create jobs, and sustain healthy local economies. Since its inception, the NMTC has generated more than one million jobs. Today, due to NMTC, more than $105 billion is hard at work in underserved communities in all 50 states, the District of Columbia, and Puerto Rico. For more information, visit www.NMTCCoalition.org. Contact Details New Markets Tax Credit Coalition Ayrianne Parks +1 202-393-5225 ayrianne@rapoza.org Company Website http://nmtccoalition.org/

February 25, 2021 09:04 AM Eastern Standard Time

Article thumbnail News Release

Medtech Startup GyroGear raises US$4.3m in Phase One of Seed Round led by Taiwan Manufacturing Giant Foxconn

Media Outreach

SINGAPORE - Media OutReach - 25 February 2021 - UK-based neuromuscular medical device company, GyroGear Ltd has just concluded phase one of its seed round fundraise. This round was led by Foxconn Technology Group, the world's largest and foremost electronics manufacturer. Foxconn has invested £1 million (US$1.41 million) upfront. Participants in GyroGear's seed round include the UK Government Future Fund, Singapore venture builder Fidelium Group, and other established strategic investors and business leaders. Phase two of the seed round is ongoing and scheduled for completion in March 2021. GyroGear is developing a wearable to help individuals with hand tremors. The wearable reduces tremors, so they may perform their day-to-day activities. This also brings relief to caregivers and family members. "In the US alone, the economic burden of Parkinson's Disease amounts to $51.9 billion every year, growing to $79.1 billion by 2037. Essential Tremor alone is up to 20 times more prevalent than Parkinson's, and can manifest at any point in one's life. The impact of not being able to use one's hands is beyond what any numbers can describe. GyroGear was founded to specifically address this large unmet medical need, and to provide simple, elegant solutions to restore the quality of life to 200 million tremor patients worldwide," explains Dr Faii Ong, Founder and CEO of GyroGear. Dr Ong adds, "Our partnership with Foxconn elevates GyroGear's existing world-class engineering and advisory base with further strategic and technical expertise. It grants GyroGear access to class-leading advanced technologies and capabilities as we ready our flagship product, the GyroGlove™, for international launch." GyroGear's flagship product, the GyroGlove™, is the world's first and only wearable medical device that adopts cutting edge aerospace technology and satellite-grade mechanical gyroscopes. The technology effectively and swiftly counteracts hand tremors, thus restoring normal use of the hand. Lightweight and efficacious, the GyroGlove™ unobtrusively empowers users to overcome their daily challenges, offering hope to the millions of tremor sufferers worldwide who struggle with everyday tasks. Potential users include those with Parkinson's Disease and Essential Tremor, with both conditions affecting over 200 million people worldwide. Prevalence of both diseases has been rapidly increasing this past decade. Current therapies include medication and neurosurgery. Medication is accompanied by significant side effects. Whereas neurosurgery is limited to a small minority of patients due to its inherent risks. There is currently no cure for hand tremors. "We are eager and excited to partner with GyroGear and bring the GyroGlove™ to Asia. The partnership is another reflection of our long-term commitment to our "3+3=∞" vision, which symbolises the infinite possibilities created by Foxconn's industrial advancement and emerging technologies," said Young-way Liu, Chairman of Foxconn Technology Group. Paul Lim, Chairman of Fidelium Group and Senior Advisor to GyroGear Ltd added, "GyroGear fills a huge gap in today's medical spectrum. Many tremor patients suffer in silence as the disease robs them not only of the ability to carry on simple daily activities, but more importantly, many suffer silently, with mental trauma caused by embarrassment from uncontrollable shaking. They avoid going out to public spaces and recluse themselves from social activities. Founder CEO Dr Faii Ong is a visionary leader who has led his team to invent this elegant solution that will change the lives of millions of tremor patients in the world." The funds raised will be used for clinical trials, regulatory approval and further R&D. This round closes March 2021. About GyroGear GyroGear Ltd is a neuromuscular medical device company incorporated in 2016 by Dr Faii Ong. It is the only medical device company worldwide to utilise mechanical gyroscopes. Whilst still a student at Imperial College London, Dr Ong was moved to action after witnessing the distress experienced by a 103-year-old Parkinson’s patient at a London hospital. Dr Ong and his team invented the GyroGlove™ as a solution to help millions in the same situation. GyroGear’s flagship product is the GyroGloveTM, a wearable device that mechanically stabilises hand tremors with cutting edge aerospace-grade gyroscopes. The GyroGlove™ has demonstrated promising results. Volunteers are able to put on the GyroGlove™ independently, and start to feed themselves, insert keys into keyholes, write once more, and for some, even thread a needle and sew again. Since its inception, GyroGear has been featured prominently in global media publications including Popular Science, MIT Technology Review, the BBC, Forbes, Reuters and the Washington Post. In December 2020, GyroGear won first runner-up out of 7,500 participating start-ups from 159 nations, at SLINGSHOT 2020. The judges were Eduardo Saverin, Forest Li, Sequoia Capital, Temasek and SG Enterprise. SLINGSHOT 2020 is the leading start-up competition in South East Asia, organised by the Singapore government. GyroGear has been awarded over $3.3M in funding from the EU Horizon 2020 and Innovate UK, to develop the GyroGlove™. GyroGear is based in London and Singapore. For further information: https://gyrogear.co/. About Foxconn Technology Group Established in Taiwan in 1974, Hon Hai Technology Group (Foxconn) (2317: Taiwan) is the world’s largest electronics manufacturer. Foxconn is also the leading technological solution provider and it continuously leverages its expertise in software and hardware to integrate its unique manufacturing systems with emerging technologies. About UK Future Fund Announced by the Government of the United Kingdom on 20th April 2020, the Future Fund issues convertible loans to innovative UK companies with good potential that typically rely on equity investment. The scheme is designed by the government and delivered by the British Business Bank. For further information: https://www.british-business-bank.co.uk/ About Fidelium Group Fidelium Group is a venture builder, investment and management consulting company with a presence in Asia, Europe, the United Kingdom and the United States. The company provides a suite of comprehensive services for SMEs and start-ups which include corporate structuring, corporate finance, fundraising and corporate secretarial services. For further information: https://fideliumgroup.com/ Contact Details Right Hook Communications Wesley Gunter +65 9679 8574 wesley@righthook.com.sg Company Website https://gyrogear.co/

February 25, 2021 09:00 AM Eastern Standard Time

Image
Article thumbnail News Release

Keeping Your Heart Healthy with Kori Krill Oil: American Heart Month

YourUpdateTV

Heart disease is the leading health-related cause of death in the United States, taking the lives of 2,200 people each day. Nearly half of American adults have at least one of the top three risk factors for heart disease: high blood pressure, high cholesterol, and smoking. February is American Heart Month, a time to learn about simple steps you can take now to help your heart. For many years, experts have recommended that people eat fatty fish rich in essential Omega-3 nutrients at least twice a week. But did you that most Americans—up to 70%— are deficient in Omega-3s because they do not eat enough fish? That’s a concern because scientific studies have shown that Omega-3s can support our heart and overall health. A video accompanying this announcement is available at: https://youtu.be/j-djtjZjb9M So, if you want to get on track to a maintaining a healthy heart but don’t know where to start, what to eat or what supplements to use, what should you do? Kori Krill Oil partnered with Dr. Taz Bhatia, D S Simon Media, and YourUpdate TV on a nationwide media tour to discuss the steps you can take to help your heart, including the heart-healthy benefits of Omega-3s. Where you get your Omega-3s from matters. Research has found that there are two critical types of Omega-3s for our health, called EPA and DHA. These are what you find in real fish and in ocean-sourced supplements like Kori Pure Antarctic Krill Oil. According to the FDA, supportive but not conclusive research shows that consumption of EPA and DHA omega-3 fatty acids may reduce the risk of coronary heart disease. One serving of Kori Krill Oil provides 250 grams of EPA and DHA Omega-3 fatty acids. [See nutrition information for total fat, saturated fat and cholesterol content.] In addition, Omega-3s support normal triglycerides, may increase good cholesterol (HDL), and support normal circulation and heart rhythm. The important thing to realize about Omega-3 fatty acids is that our bodies can’t make them on their own. We have to consume them. Krill oil has been clinically proven to raise Omega-3 levels and is a doctor recommended Omega-3 source. Kori Krill Oil has superior Omega-3 absorption vs fish oil because it delivers Omega-3s in their most natural form, just as you would find in real fish. Plus, it has no fishy aftertaste. In addition to Omega-3s, Kori Krill Oil is also naturally a good source of choline, another essential nutrient that supports brain and nervous system health, and has an antioxidant. You won’t find either of these in fish oil. It even comes in small and mini sizes for people who have trouble swallowing large pills. Kori Krill Oil has a commitment to purity and quality. It’s certified sustainably sourced from pristine Antarctic waters and does not add artificial ingredients. For more information about supporting your heart health visit korikrilloil.com You can get Kori Krill Oil at Walmart, CVS and other retailers. About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

February 24, 2021 09:00 AM Eastern Standard Time

Video
Article thumbnail News Release

MEDICAL PROFESSIONALS & PATIENT ADVOCATES APPLAUD U.S. SENATE BILL TO STUDY ROLE OF PBM INDUSTRY

Alliance for Transparent & Affordable Prescriptions

A new Bill introduced in the United States Senate on February 8, 2021 to study the pharmacy benefit manager (PBM) industry is moving forward with a referral to the Committee on Health, Education, Labor, and Pensions for consideration. The proposal, S. 298 is being met with optimism by medical professionals and patient advocates from the Alliance for Transparent and Affordable Prescriptions (ATAP) with direct experience with these “middlemen” that place upward pressure on prescription drug pricing. The Senate Bill introduced by Senator Marsha Blackburn (TN) and cosponsored by Senator Mike Braun (IN) will “…require the Government Accountability Office to study the role pharmaceutical benefit managers play in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes…” “Anything that shines a light on the PBM industry is a wonderful first step,” stated ATAP’s President Dr. Robert Levin. “For far too long, PBMs generated significant profits while patients struggle to afford the cost of prescription drugs. It is time that elected officials and policy makers see what it really happening in our exam rooms, and our patient’s wallets, due to PBM interference. ATAP has been an active advocate for patients in a variety of federal and state battles to amplify the voices of patients and physicians. “Surely if this Bill passes, the study will show what we see every day. Patients are suffering under the current system that allows PBMs to put obstacles between patients and the medicine they need,” stated Dr. Michael Schweitz of the Coalition of State Rheumatology Organizations, and ATAP member organization. “Now that light is shining on the previously hidden profit motives of the PBM industry, patients, physicians, and policy makers will have the power to effect meaningful change.” In addition to legislative efforts, ATAP filed an Amicus Brief with the United States Supreme Court that argued in part that PBMs are engaged in abusive practices with serious practical and policy consequences – including upward pressure on prescription drug pricing. The case, Rutledge vs Pharmaceutical Care Management Association (PCMA) resulted in a unanimous 8-0 decision where Justices agreed that states have the rights to impose regulations on PBMs. Dr. Angus Worthing of the American College of Rheumatology, an ATAP member organization stated, “The United States Senate, the Supreme Court, and state legislators across the country are realizing on a bipartisan basis how the hidden profit motives of the PBM industry are harming patients. More transparency is desperately needed, and the latest Senate proposal will provide it.” ATAP continues to support efforts to force the PBM industry to disclose rebate data and encourage transparency and reporting requirements for all entities involved in the prescription drug supply chain – PBMs, insurers, and manufacturers. ### To schedule an interview with Dr. Levin or another ATAP spokesperson, please contact Dan Rene of kglobal at 202-329-8357. Please visit http://www.atapadvocates.com ATAP's mission is to address prescription drugs costs and patient access to affordable treatment by regulating PBM practices and reforming the drug industry through educational outreach and grassroots advocacy initiatives at both the state and federal level. Contact Details Alliance for Transparent and Affordable Prescriptions Dan Rene +1 202-329-8357 daniel.rene@kglobal.com Company Website http://www.atapadvocates.com

February 23, 2021 05:10 PM Eastern Standard Time

1 ... 282283284285286 ... 305